Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Public ClinicalTrials.gov record NCT05294328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Masked Evaluation of the Safety and Effectiveness of Aceclidine /Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Study identification
- NCT ID
- NCT05294328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- LENZ Therapeutics, Inc
- Other
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Interventions
- Aceclidine+Brimonidine combination ophthalmic solution Drug
- Aceclidine ophthalmic solution Drug
- Vehicle Proprietary Ophthalmic Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2022
- Primary completion
- Aug 21, 2022
- Completion
- Sep 9, 2022
- Last update posted
- Sep 4, 2024
2022
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| INSIGHT-1 Study Site #4 | Glendale | California | 91204 | — |
| INSIGHT-1 Study Site #3 | Indianapolis | Indiana | 46240 | — |
| INSIGHT-1 Study Site #1 | Andover | Massachusetts | 01810 | — |
| INSIGHT-1 Study Site #2 | Memphis | Tennessee | 38119 | — |
| INSIGHT-1 Study Site #5 | Houston | Texas | 77027 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05294328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05294328 live on ClinicalTrials.gov.